May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Trans–Tenon's Retrobulbar Triamcinolone Infusion for Macular Edema Associated With Branch Retinal Vein Occlusion Remaining After Vitrectomy
Author Affiliations & Notes
  • M. Fukushima
    Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • T. Kawaji
    Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • N. Awai
    Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • A. Takano
    Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • Y. Inomata
    Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • A. Hirata
    Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • H. Tanihara
    Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • Footnotes
    Commercial Relationships  M. Fukushima, None; T. Kawaji, None; N. Awai, None; A. Takano, None; Y. Inomata, None; A. Hirata, None; H. Tanihara, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4041. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Fukushima, T. Kawaji, N. Awai, A. Takano, Y. Inomata, A. Hirata, H. Tanihara; Trans–Tenon's Retrobulbar Triamcinolone Infusion for Macular Edema Associated With Branch Retinal Vein Occlusion Remaining After Vitrectomy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4041.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the safety and effectiveness of trans–Tenon’s retrobulbar triamcinolone infusion for macular edema associated with branch retinal vein occlusion (BRVO) remaining even after vitrectomy Methods: Twenty eyes of 20 patients with BRVO, characterized by macular edema remaining more than 3 months even after vitrectomy, were enrolled in this study. Trans–Tenon’s retrobulbar infusion of 40mg triamcinolone was performed. Visual acuity, retinal thickness measured by optical coherence tomography (OCT), fluorescein angiography and intraocular pressure (IOP) were evaluated. Results: The mean duration (± standard deviation) between surgeries and triamcinolone infusion was 7.7 ± 4.5 months (range, 3–21 months). The mean foveal thickness was 499.4 ± 209.1 µm, 281.8 ± 110.1µm, and 196.9 ± 92.1 µm, respectively, preoperatively, at 2 weeks, and at 6 months follow–up. Statistical analysis showed significant differences between preoperative and postoperative measurements (P<.0001, at 2 weeks and 6 months, paired t–test). Visual acuity improved significantly from preoperative 0.74 ± 0.26 logMAR (range, 1.1 to 0.3) to 0.46 ± 0.31 logMAR (range, 1.0 to 0) (P<.0001) at 6 months follow–up. Improvement of visual acuity by at least 0.20 logMAR was seen in 14 (70%) of the 20 eyes. In all of the treated eyes, vascular leakiness shown by the fluorescein angiograms was improved at 1 month follow–up. Intraocular pressure (IOP) elevation of 22 mmHg or higher was found in 7 (35%) of the 20 eyes, and IOP was controlled with anti–glaucoma medications in all cases. Conclusions:Our studies showed that trans–Tenon’s retrobulbar triamcinolone infusion is safe and effective for macular edema associated with BRVO remaining after vitrectomy.

Keywords: retina • corticosteroids • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×